Financial Updates for the Psychedelics Industry | Microdose

Psychedelics News

Finance

17 May 2022

MindMed Prepares to Raise Up to $100M in Capital

MindMed announced the approval for shares to be sold for up to $100,000,000 in aggregate sales in "at the market" transactions (at market price)...

By Microdose NewsDesk

Finance

17 May 2022

Microdose’s Deal Board Helps Democratize Psychedelic Investing

Microdose is doing its part in helping democratize investment opportunities....

By Microdose

Finance

11 May 2022

Enveric to Split Into Two Companies; Spin-off Cannabinoid Pipeline

The proposed spin-off would create two separate and distinct biotechnology companies, one developing next-generation psychedelic-inspired treatments and the other developing innovative cannabinoid treatments...

By Microdose NewsDesk

Finance

6 May 2022

MindMed Receives 700% Price Target From Roth Capital

Roth Capital Partners has initiated coverage on MindMed with a $7 price target, over 700% the current stock price....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Finance

26 Apr 2022

PharmaTher Reports Q3 Financial and Business Highlights

PharmaTher continues to be one of those under-the-radar firms, consistently putting out positive news and moving its pipeline forward....

By Jason Najum

Breaking News, Finance

19 Apr 2022

Nue Life Closes $23 million Series A Financing

Nue Life, a telemedicine startup building a mental wellness platform, has just closed a $23 million Series A equity financing....

By Jason Najum

Finance

15 Apr 2022

Mydecine Announces Reverse Stock-Split

Mydecine announced an upcoming reverse stock-split....

By Jason Najum

Finance

8 Apr 2022

Christian Angermayer Buys 1 Million Shares of ATAI

Psychedelic medicine is a long-term play and atai founder Christian Angermayer has just given us a multi-million dollar reminder...

By Jason Najum

Finance

1 Apr 2022

Mydecine Releases 2021 Financials and Announces Capital Raise

We're combining two announcements here....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result